Here’s Otsuka’s digital health strategy around mental health
Otsuka's top U.S.-based leaders spoke about the company's partnerships in mental health and how it is driving innovation in big pharma.
Otsuka's top U.S.-based leaders spoke about the company's partnerships in mental health and how it is driving innovation in big pharma.
Proteus Digital Health paired its ingestible sensor platform with Otsuka Pharmaceuticals' FDA-approved Abilify drug to treat people with schizophrenia and other serious mental health problems to monitor adherence.
Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.